Abstract
Inhibition of STAT3 signaling pathway is proposed to be a promising strategy for cancer treatment. In this study, a series of 4-carbonyl-2,6-dibenzylidenecyclohexanone derivatives were prepared and evaluated as anticancer agents. The most potent compound 13r was discovered to exhibit antiproliferative activity against a broad rang of cancer cell lines and relatively low cytotoxicity against normal human cells. Besides, 13r effectively suppressed STAT3 expression as well as phosphorylation, and surface plasmon resonance analysis confirmed the direct interaction of 13r with STAT3. Docking simulation showed that 13r could inhibit STAT3 by targeting SH2 domain. This study provided evidence for these compounds to be further developed as antitumor agents through inhibition of the STAT3 pathway.
Keywords:
Antitumor; Apoptosis; Curcumin; Inhibitors; STAT3.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
A549 Cells
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Apoptosis / drug effects
-
Benzylidene Compounds / chemical synthesis
-
Benzylidene Compounds / chemistry
-
Benzylidene Compounds / pharmacology*
-
Catalytic Domain
-
Cyclohexanones / chemical synthesis
-
Cyclohexanones / chemistry
-
Cyclohexanones / pharmacology*
-
Humans
-
Molecular Docking Simulation
-
Phosphorylation
-
Poly(ADP-ribose) Polymerases / metabolism
-
STAT3 Transcription Factor / antagonists & inhibitors*
-
STAT3 Transcription Factor / metabolism
-
Signal Transduction / drug effects
-
Structure-Activity Relationship
-
src Homology Domains
Substances
-
Antineoplastic Agents
-
Benzylidene Compounds
-
Cyclohexanones
-
N-(2-(diethylamino)ethyl)-3,5-bis(4-fluorobenzylidene)-4-oxocyclohexanecarboxamide
-
STAT3 Transcription Factor
-
Poly(ADP-ribose) Polymerases